Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

The Lancet

Volumn 339, Issue 8791, 1992, Pages 441-445

  Prandoni, P ^a   Carta, M ^a   Cogo, A ^a   Ruol, A ^a   Vigo, M ^a   Casara, D ^a   Lensing, A W A ^b   Buller H R ^b   ten Cate, J W ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG ADMINISTRATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; PULMONARY EMBOLISM; RECURRENCE; RISK; SUPPORT, NON-U.S. GOV'T; THROMBOCYTOPENIA; THROMBOPHLEBITIS;

EID: 0026569416     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)91054-C     Document Type: Article

References (29)

1. Treatment of venous thromboembolism
2. Heparin
3. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the treatment of proximal-vein thrombosis
4. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism
5. Heparin for 5 days as compared with 10 days in the initial treatment of proximal-vein thrombosis
6. The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits; clinical implications
7. Comparative trial of heparin and oral anticoagulants in the initial treatment of proximal deep-vein thrombosis
8. Low molecular weight heparin; is small beautiful?
9. From unfractionated heparins to low molecular weight heparins
10. The antithrombotic activity and pharmacokinetics of enoxaparin a low molecular weight heparin in man given single subcutaneous doses of 20 up to 80 mg
11. Unfractionated heparin and CY216: pharmacokinetics and bioavailabilities of the anti-Factor Xa and IIa: effects of intravenous and subcutaneous injection in rabbits
12. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
13. Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin
14. Subcutaneous heparin treatment of deep vein thrombosis: a comparison of unfractionated and low molecular weight heparin
15. Treatment of acute venous thromboembolism with low molecular weight heparin
16. Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis
17. A randomized trial of subcutaneous low molecular weight heparin (CY216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis
18. A new computerized impedance plethysmograph: accuracy in the detection of proximal deep vein thrombosis in symptomatic outpatients
19. Detection of deep-vein thrombosis by real-time B-mode ultrasonography
20. An objective doppler method for the diagnosis of deep-vein thrombosis
21. Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep vein thrombosis
22. Contrast venography, the gold standard for the diagnosis of deep vein thrombosis: improvement in observer agreement
23. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy
24. Ventilation-perfusion scanning and the diagnosis of pulmonary embolism: improvement of observer agreement by the use of a lung segment reference chart
25. The diagnosis of acute recurrent deep-vein thrombosis: a diagnostic challenge
26. A table of exact confidence limits for differences and ratios of two proportions and their odds ratios
27. Venous thrombosis in the lower limbs its relation to pulmonary embolism
28. Overview of the management of thromboembolic disorders
29. Low molecular weight heparin